Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.02 USD
Change Today -0.0005 / -3.13%
Volume 679.1K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

oxis international inc (OXIS) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
03/31/15 - $0.07
52 Week Low
10/6/14 - $0.01
Market Cap
9.3M
Average Volume 10 Days
1.2M
EPS TTM
$-0.04
Shares Outstanding
600.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OXIS INTERNATIONAL INC (OXIS)

Related News

No related news articles were found.

oxis international inc (OXIS) Related Businessweek News

No Related Businessweek News Found

oxis international inc (OXIS) Details

Oxis International, Inc., through its subsidiary, Oxis Biotech, Inc., discovers, develops, and commercializes therapeutics from its proprietary product platform in various disease areas in the United States. The company is developing drugs for the treatment of cancer and other unmet medical needs. Its lead drug candidates include OXS-2175, a small molecule therapeutic candidate for the treatment of triple-negative breast cancer; and OXS-4235, a small molecule therapeutic candidate to treat multiple myeloma and associated osteolytic lesions. The company was formerly known as DDI Pharmaceuticals, Inc. and changed its name to Oxis International, Inc. in 1994. Oxis International, Inc. was founded in 1965 and is based in Tampa, Florida.

2 Employees
Last Reported Date: 03/31/15
Founded in 1965

oxis international inc (OXIS) Top Compensated Officers

Chairman of the Board and Chief Executive Off...
Total Annual Compensation: $154.0K
President, Chief Financial Officer, Chief Acc...
Total Annual Compensation: $25.5K
Compensation as of Fiscal Year 2014.

oxis international inc (OXIS) Key Developments

Oxis International Appoints Cassian Yee, M.D. to its Scientific Advisory Board

Oxis International, Inc. announced that Cassian Yee, M.D., Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center joined its scientific advisory board. Dr. Yee is also Professor, Department of Immunology, Division of Cancer Medicine, and Director, Solid Tumor Cell Therapy, Center for Cancer Immunology Research at the University of Texas MD Anderson Cancer Center. Dr. Yee previously held the position of Professor in Division of Oncology at the University of Washington, and was a Member in the Department of Immunology, Clinical Research Division of the Fred Hutchinson Cancer Research Center.

OXIS International, Inc. Auditor Raises 'Going Concern' Doubt

OXIS International, Inc. filed its 10-K on Mar 31, 2015 for the period ending Dec 31, 2014. In this report its auditor, Seligson & Giannattasio, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

OXIS International, Inc. - Shareholder/Analyst Call

To update shareholders and other interested parties on corporate developments at Oxis Biotech, Inc

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXIS:US $0.02 USD -0.0005

OXIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lifeway Foods Inc $14.10 USD +0.36
Monster Beverage Corp $140.43 USD +0.42
Nu Skin Enterprises Inc $45.75 USD +0.59
Estee Lauder Cos Inc/The $80.35 USD +0.28
Hain Celestial Group Inc/The $62.19 USD +0.23
View Industry Companies
 

Industry Analysis

OXIS

Industry Average

Valuation OXIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 147.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 78.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OXIS INTERNATIONAL INC, please visit oxis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.